- 2025-04-12 17:33PP1 172889-26-8
- 2025-04-12 17:33NM-107 20724-73-6
- 2025-04-12 17:33(3R)-7,4'-Dihydrohomoisoflavanone 1178893-64-5
- 2025-04-12 17:33ALK-IN-9 2359662-39-6
- 2025-04-12 17:33(2RS)-FPMPA 135295-27-1
- 2025-04-12 17:33LETERMOVIR 917389-32-3
- 2025-04-12 17:33(S,S)-Valifenalate ((S,S)-IR5885; (S,S)-Valiphenal) 283159-94-4
- 2025-04-12 17:33Aflibercept (VEGF Trap) 862111-32-8
- 2025-04-12 17:33Anti-Human/Rat HER2 (neu) Antibody (7.16.4)
- 2025-04-12 17:33Val-Cit-amide-Ph-Maytansine
- 2025-04-12 17:33IALYLQQNW 610268-80-9
- 2025-04-12 17:33AMPK activator 12 431920-24-0
- 2025-04-12 17:33(2R,4S)-1-(tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid 147266-92-0
- 2025-04-12 17:337-Aminomethyl-10-methyl-11-fluoro camptothecin TFA
- 2025-04-12 17:33Ac-DEMEEC-OH 208921-05-5
- 2025-04-12 17:33Exatecan Intermediate 3
- 2025-04-12 17:33FLT3-IN-10 2088735-51-5
- 2025-04-12 17:33cis-Resveratrol (cis-resveratrol) 61434-67-1
- 2025-04-12 17:33Syk Inhibitor II dihydrochloride 227449-73-2
- 2025-04-12 17:33Btk substrate peptide
